Emilio Ciusani Selected Research

Emilio Ciusani Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 02/2004
18	Glioma (Gliomas) 05/2021 - 03/2002
10	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 03/2002
6	Carcinoma (Carcinomatosis) 12/2021 - 03/2006
6	Melanoma (Melanoma, Malignant) 05/2021 - 12/2010
4	Multiple Sclerosis 02/2022 - 06/2002
4	Inflammation (Inflammations) 12/2021 - 09/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2019
2	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2017 - 03/2012
2	Drug Resistant Epilepsy 01/2017 - 03/2011
2	Seizures (Absence Seizure) 01/2017 - 03/2011
2	Neoplasm Metastasis (Metastasis) 08/2015 - 01/2009
2	Demyelinating Diseases (Demyelinating Disease) 09/2013 - 02/2006
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2021
1	Mesothelioma 12/2021
1	Ketosis 01/2021
1	Epilepsy (Aura) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Disease Susceptibility (Diathesis) 03/2019
1	Disease Progression 03/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019
1	Necrosis 12/2018
1	Muscle Spasticity (Spastic) 08/2018
1	Meningioma (Meningiomas) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Prescription Drug Overuse 05/2017
1	Pain (Aches) 05/2017
1	Migraine Disorders (Migraine) 05/2017

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 11/2017 - 03/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 02/2019 - 01/2011
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2004
5	Conditioned Culture MediaIBA 03/2015 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2008
4	LigandsIBA 12/2021 - 01/2005
4	Temozolomide (Temodar)FDA LinkGeneric 05/2021 - 01/2004
4	Biomarkers (Surrogate Marker)IBA 03/2019 - 12/2010
3	Antineoplastic Agents (Antineoplastics)IBA 12/2021 - 01/2006
3	Drug CombinationsIBA 05/2021 - 06/2014
3	EnzymesIBA 05/2021 - 02/2006
3	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2011
3	PlatinumIBA 07/2019 - 01/2018
3	Biological ProductsIBA 03/2019 - 03/2015
3	matrigelIBA 01/2017 - 01/2006
3	AntibodiesIBA 01/2016 - 09/2012
3	ChemokinesIBA 06/2014 - 06/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2005
3	Plasminogen Activator Inhibitor 1IBA 02/2006 - 02/2004
2	Immunoglobulin G (IgG)IBA 02/2022 - 09/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 01/2018
2	CytokinesIBA 01/2019 - 01/2014
2	IntegrinsIBA 12/2018 - 01/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017 - 06/2014
2	MicroRNAs (MicroRNA)IBA 01/2017 - 10/2015
2	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2011 - 05/2004
2	HomocysteineIBA 05/2008 - 02/2004
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2005 - 01/2004
2	Topoisomerase I InhibitorsIBA 01/2005 - 03/2002
1	BNT162 VaccineIBA 02/2022
1	VaccinesIBA 02/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	LipidsIBA 12/2021
1	8-aminoquinolineIBA 12/2021
1	Orlistat (Xenical)FDA Link 05/2021
1	VemurafenibIBA 05/2021
1	perampanelIBA 05/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	KetonesIBA 01/2021
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021
1	isospaglumic acid (NAAGA)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Histone Deacetylase 6IBA 01/2020
1	AZD 6244IBA 01/2020
1	ricolinostatIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Cystatin BIBA 01/2020
1	Polystyrenes (Polystyrene)IBA 11/2019
1	SB 203580IBA 07/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2019
1	statticIBA 07/2019
1	PorphyrinsIBA 01/2019
1	T 0070907IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	marycinIBA 01/2019
1	ProteomeIBA 01/2019
1	Nucleosomes (Nucleosome)IBA 12/2018
1	AnnexinsIBA 12/2018
1	Type A Botulinum Toxins (Botox)FDA Link 08/2018
1	selinexorIBA 01/2018
1	Complex MixturesIBA 05/2017
1	pantothenate kinaseIBA 01/2017

Therapy/Procedure

11	Therapeutics 02/2022 - 03/2002
5	Drug Therapy (Chemotherapy) 12/2018 - 01/2007
3	Ketogenic Diet 01/2021 - 01/2014
3	Radiotherapy 01/2018 - 05/2012
1	Castration 01/2020